Patterns and correlates of cannabis use among individuals with HIV/AIDS in maritime Canada

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 25, Issue 1, 2014, Pages

  Harris, Gregory E ^a   Dupuis, Lise ^b   Mugford, Gerald J ^c   Johnston, Lynn ^d   Haase, David ^e   Page, Ginny ^f   Haldane, Heather ^g   Harris, Nicholas ^h   Midodzi, William K ^a   Dow, Gordon ^e  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b HORIZON HEALTH NETWORK   (Canada)

^c Health Sciences Centre St John's   (Canada)

^d Capital District Health Authority   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^g Centre for Clinical Research   (Canada)

^h LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Cannabis; High risk behaviour; HIV AIDS

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; APPETITE STIMULANT; MEDICAL CANNABIS; RECREATIONAL DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANOREXIA; ANXIETY; ARTICLE; CANADA; CANNABIS USE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG USE; EUPHORIA; FEEDING BEHAVIOR; FEMALE; HIGH RISK BEHAVIOR; HOPELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PAIN; PLEASURE; PREDICTOR VARIABLE; PREVALENCE; RURAL AREA; SELF CONCEPT; STRESS MANAGEMENT; SUICIDAL IDEATION; TOBACCO USE; UNSAFE SEX;

EID: 84897470073     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2014/301713     Document Type: Article

References (48)

1. Kogan N, Mechoulam R. Cannabinoids in health and disease. Dialogue S Clin Neurosci 2007;9;413-30. (Pubitemid 351187565)
2. United Nations Office on Drugs and Crime. World Drug Report 2011. United Nations Publication. 2011. 〈http://www.unodc.org/unodc/en/data-and- analysis/WDR-2011.html〉 (Accessed March 2013).
3. United Nations Office on Drugs and Crime.World Drug Report 2007. 2007. 〈http://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html〉 (Accessed March 2013).
4. Canadian Centre on Substance Abuse. Canadian Addiction Survey. 2004. 〈www.ccsa.ca/eng/priorities/research/canadianaddiction/pages/default. aspx〉 (Accessed March 2013).
5. Mechoulam R. The pharmacohistory of cannabis sativa. In: Mechoulam R, ed. Cannabinoids as therapeutic agents. Boca Raton: CRC Press, 1986:1-19.
6. Erickson B. Controlled Drugs and Substances Act-Marijuana Medical Access Regulations Registration Sor 2001-277 (JUS-602460). Ottawa: Policy and Regulatory Affairs Division, 2001.
7. Health Canada. Stakeholders Statistics. Ottawa: Health Canada, 2012. 〈http://www.hc-sc.gc.ca/dhp-mps/marihuana/stat/index-eng.php〉 (Accessed March 2013).
8. Belle-Isle L, Hathaway A. Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care 2007;19:500-6. (Pubitemid 46598747)
9. Furler M, Einarson T, Millson M, Walmsley S, Bendayan R. Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDs 2004;18:215-28. (Pubitemid 38558998)
10. Wang T, Collet JP, Shapiro S, Ware M. Adverse effects of medical cannabinoids: A systematic review. CMAJ 2008;178:1669-78. (Pubitemid 351899653)
11. Bovasso G. Cannabis use as a risk factor for depressive symptoms. Am J Psychiatr 2001;158:2033-7. (Pubitemid 33104110)
12. Sewell R, Ranganathan M, D'Souza D. Cannabinoids and psychosis. Int Rev Psych 2009;21:152-62.
13. Lynsky M, Hall W. The effects of adolescent cannabis use on educational attainment: A review. Addiction 2000;95:1621-30.
14. Wadsworth E, Moss S, Simpson S, Smith A. Cannabis use, cognitive performance and mood in a sample of workers. J Psychopharmocol 2006,20:14-23.
15. Asbridge M, Hayden J, Cartwright J. Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis. BMJ 2012;344-536.
16. Smith A, Ferris J, Simpson J, Shelley J, Pitts M, Richters J. Cannabis use in sexual health. J Sex Med 2010;7(2 pt 1):787-93.
17. Tan W, Low C, Jong A, et al. Marijuana and chronic obstructive lung disease: A population-based study. CMAJ 2009;180:814-20.
18. Quoix E. What is new in the epidemiology of lung cancer: Non-smokers, women and the role of cannabis? Rev Prat 2009;59:920-24.
19. Reece A. Chronic toxicology of cannabis. Clin Toxicol (Phila) 2009;47:517-24.
20. Friedman H, Newton C, Klein T. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003;16:209-19. (Pubitemid 36519808)
21. Bagshaw S, Haggen N. Medical efficacy of cannabinoids and marijuana: A comprehensive review of the literature. J Palliat Care 2002;18:111-22.
22. Braitstein P, Kendall T, Chan K, et al. Mary-jane and her patients: Sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS 2001;15:532-33. (Pubitemid 32207577)
23. Ware M, Rueda S, Singer J, Kilbey D. Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. J Cannabis Therapeut 2003;3:3-15. (Pubitemid 36889409)
24. Schwarzer R, Jerusalem M. Generalized Self-Efficacy Scale. In: Weinman J, Wright S, Johnson M, eds. Measures in health psychology: A user's portfolio. Causal and control beliefs. Windsor: NFER-NELSON, 1995;35-7.
25. Beck AT, Steer RA. Beck Hopelessness Scale manual. San Antonio, Orlando: The Psychological Corporation, 1993.
26. Derogatis LR. Brief Symptom Inventory (BSI)-18. Administration, scoring and procedures manual. Minneapolis: NCS Pearson, 2011.
27. Lemstra M, Bennett N, Neudorf C et al. A meta-analysis of marijuana and alcohol use by socio-economic status in adolescents aged 10-15 years. Can J Public Health 2008;99:172-7.
28. Sidney S. Marijuana use in HIV-positive and AIDS patients: Results of anonymous mail survey. J Cannabis Therapeut 2001;1:35-41.
29. Leatherdale S, Hammond D, Kaiserman M, Rashid A. Marijuana and tobacco use among young adults in Canada: Are they smoking what they think they are smoking? Cancer Causes Control 2007;18:391-7. (Pubitemid 46434790)
30. Dansak D. Medical use of recreational drugs by AIDS patients. J Addict Dis 1997;16:25-30. (Pubitemid 27348248)
31. Prentiss D, Power R, Balmas G, Tzuang G, Israelski M. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 2004;35:38-45. (Pubitemid 38044780)
32. Beal J, Olson R, Laubenstein L, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage 1995;10:89-97.
33. Haney M, Rabkin J, Gunderson E, Foltin R. Dronabinol and marijuana in HIV(+) marijuana smokers: Acute effects on caloric intake and mood. Psychopharmacology 2005;181:170-5.
34. Struwe M, Kaempfer S, Geiger C, et al. Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 1993;27:827-31. (Pubitemid 23225663)
35. Timpone J, Wright D, Li N, Egorin M, et al. The safety and pharmacokinetics of single-agent and combination therapy with magesterol acetate and dronabinol for the treatment of HIV wasting syndrome. AIDS Res Hum Retroviruses 1997;13:305-15. (Pubitemid 27117943)
36. Bravo P, Edwards A, Rollnick S, Elwyn G. Tough decisions faced with people living with HIV: A literature of psychosocial problems. AIDS Rev 2010;12:76-88.
37. Rabkin J. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep 2008;5:163-71.
38. Sewell R, Poling J, Sofuoglu M. The effect of cannabis compared with alcohol on driving. Am J Addict 2009;18:185-93.
39. Ellis R, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: A randomized crossover clinical trial. Neuropsychopharmacology 2009;34:672-80.
40. Pope H, Gruber A, Hudson J, Huestis M, Yurgelum-Todd D. Neuropsychological performance in long-term cannabis users. Archiv Gen Psychiatr 2001;58:909-15. (Pubitemid 32937912)
41. Australia's National Research Centre on AOD Workforce Development. Fact sheet 2: Cannabis and work.
42. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383-91.
43. Blows S, Ivers R, Connor J, Ameratunga S, Woodward M, Norton R. Marijuana use in car crash injury. Addiction 2005;100:605-11. (Pubitemid 40646285)
44. Krentz H, Kliewer G, Gill M. Changing mortality rates and causes of death for HIV-infected individuals living in southern Alberta, Canada from 1984-2003. HIV Med 2005;6:99-106. (Pubitemid 40425973)
45. Brook J, Balka E, Whiteman M. The risks for late adolescence of early adolescent marijuana use. Am J Public Health 1999;89:1549-54. (Pubitemid 29457910)
46. Wu L, Pilowsky D, Schlenger W. High prevalence of substance use disorders among adolescents who use marijuana and inhalants. Drug Alcohol Depend 2005;78:23-32. (Pubitemid 40354173)
47. Nahvi S, Cooperman N. Review: The need for smoking cessation among HIV-positive smokers. AIDS Educ Prev 2009;21(3 Suppl):14-27.
48. Rahmanian S, Wewers M, Koleta S, Reynolds, N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc 2011;8:313-90.